 |
 |
|
|
RESÚMENES DICIEMBRE 2007 |
Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la
región iberoamericana
3 - Substantial Genetic Overlap Between Neurocognition and Schizophrenia. Genetic Modeling in Twin Samples
Timothea Toulopoulou,
Marco Picchioni, Fruhling Rijsdijk, Mei Hua-Hall, Ulrich Ettinger, Pak Sham, Robin Murray
Arch Gen Psychiatry. 2007;64(12):1348-1355
3 - Risk of Malignancy in
Patients With Schizophrenia or Bipolar Disorder. Nested Case-Control Study
Julia Hippisley-Cox,
Arch Gen Psychiatry. 2007;64(12):1368-1376
3 - Quetiapine: Dose-Response Relationship in Schizophrenia
Sparshatt, Anna; Jones, Sarah; Taylor, David
4! - Mortality Risk in Patients With
Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical
Trials
Arif Khan, Kelly
Schwartz, Chelsea Stern; Nick Redding, Russell L. Kolts, Walter A. Brown, and
Donald S. Robinson
J Clin Psychiatry 2007;68:1828-1833
3! -
Adiponectin as a Potential Biomarker for the
Metabolic Syndrome in Chinese Patients Taking Clozapine
for Schizophrenia
Ya Mei Bai, Jen-Yeu Chen, Wei-Shiung Yang, Yu-Chiao Chi, Ying-Jay Liou, Chao-Cheng
Lin, Ying-Chieh Wang, Chih-Yuan
Lin, Tung-Pine Su, and Pesus Chou
J Clin Psychiatry 2007;68:1834-1839
5 - Ethyl-Eicosapentaenoic
Acid in First-Episode Psychosis: A Randomized, Placebo-Controlled Trial
Gregor E. Berger, Tina-Marie Proffitt,
Mirabel McConchie, HokPan Yuen, Stephen J. Wood, G. Paul Amminger, Warrick Brewer, and Patrick D. McGorry
J Clin Psychiatry 2007;68:1867-1875
5 -
Comparison of Intramuscular Ziprasidone, Olanzapine, or Aripiprazole for
Agitation: A Quantitative Review of Efficacy and Safety
Leslie Citrome
J Clin Psychiatry 2007;68:1876-1885
4 -
Comparative Assessment of the Incidence and Severity of Tardive
Dyskinesia in Patients Receiving Aripiprazole
or Haloperidol for the Treatment of Schizophrenia: A Post Hoc Analysis
Del D. Miller, James M. Eudicone,
Andrei Pikalov, and Edward Kim
J Clin Psychiatry 2007;68:1901-1906
3 -
Alcohol and Cannabis Use in Urban, African American, First-Episode
Schizophrenia-Spectrum Patients: Associations With
Positive and Negative Symptoms
Michael T. Compton, Neil E. Whicker, and
Karen M. Hochman
J Clin Psychiatry 2007;68:1939-1945
GRATIS 3 - Sarcosine
(N-Methylglycine) Treatment for Acute Schizophrenia:
A Randomized, Double-Blind Study
Biological
Psychiatry. Volume 63, Issue 1, 1 January 2008, Pages 9-12
GRATIS 3! -
Ethnic Stratification of the Association of RGS4 Variants with Antipsychotic Treatment Response in
Schizophrenia
Daniel B.
Campbell, Philip J. Ebert, Tara Skelly, T. Scott
Stroup, Jeffrey Lieberman, Pat Levitt and Patrick F. Sullivan
Biological
Psychiatry. Volume 63, Issue 1, 1 January 2008, Pages 32-41
3 - Minor physical anomalies in
patients with first-episode psychosis: their frequency and diagnostic
specificity
T. Lloyd, P. Dazzan, K. Dean, S. B. G. Park, P. Fearon, G. A. Doody, J.
Tarrant, K. D. Morgan, C. Morgan, G. Hutchinson, J. Leff,
G. Harrison, R. M. Murray and P. B. Jones
Psychological
Medicine (2008), 38:71-77
3 - Naturalistic follow-up of
co-morbid substance use in schizophrenia: the
I. Harrison, E. M. Joyce,
S. H. Mutsatsa, S. B. Hutton, V. Huddy, M. Kapasi and
T. R. E. Barnes
Psychological
Medicine (2008), 38:79-88
GRATIS 3! - Atypical
antipsychotic-induced metabolic side effects: insights from receptor-binding
profiles
H A Nasrallah
Molecular Psychiatry (2008) 13,
27–35
3! - Physiology of Schizophrenia, Bipolar Disorder, and
Schizoaffective Disorder
Laura F. Martin, Mei-Hua Hall, Randal G.
Ross, Gary Zerbe, Robert Freedman, and Ann Olincy
Am J Psychiatry 164:1900-1906,
December 2007
3! - One-Year
Outcome and Its Prediction in First-Episode Schizophrenia - A Naturalistic
Study
Silke Bachmann, Christina Bottmer, Johannes Schröder
Psychopathology 2008;41:115-123
GRATIS 3 - Sex Difference
in Cognitive Response to Antipsychotic Treatment in First Episode Schizophrenia
Leah H Rubin,
Gretchen L Haas, Matcheri S Keshavan, John A Sweeney and Pauline M Maki
Neuropsychopharmacology (2008) 33, 290–297
GRATIS 3! - D2
Receptor Occupancy of Olanzapine Pamoate
Depot Using Positron Emission Tomography: An Open-label Study in Patients with
Schizophrenia
David Mamo, Shitij Kapur, Matcheri Keshavan, Marc Laruelle,
Cindy C Taylor, Prajakti A Kothare, Penny Barsoum and
David McDonnell
Neuropsychopharmacology (2008) 33, 298–304
3 - Effects of the
Dopamine D3 Receptor (DRD3)
Gene Polymorphisms on Risperidone Response: A Pharmacogenetic Study
Jiekun Xuan, Xinzhi Zhao, Guang He, Lan Yu,
Lei Wang, Wei Tang, Xingwang Li, Niufan Gu, Guoyin Feng, Qinghe Xing and Lin He
Neuropsychopharmacology (2008) 33, 305–311
3 - Assessment and treatment of suicide risk in
schizophrenia
Maurizio Pompili, David Lester, Marco Innamorati,
Roberto Tatarelli and Paolo Girardi
Expert Review of Neurotherapeutics. January 2008, Vol. 8, No. 1, Pages 51-74
GRATIS 3! - Efficacy and Tolerability of Second-Generation Antipsychotics in
Children and Adolescents With Schizophrenia
Sanjiv Kumra,
Joel V. Oberstar, Linmarie Sikich, Robert L. Findling, Jon M. McClellan, Sophia Vinogradov
and S. Charles Schulz
Schizophrenia Bulletin 2008
34(1):60-71
3 -
Disorders of Thought Are Severe Mood Disorders: the Selective Attention Defect
in Mania Challenges the Kraepelinian Dichotomy—A
Review
C.
Schizophrenia
Bulletin 2008 34(1):109-117
GRATIS 3! - Outpatient
Antipsychotic Treatment and Inpatient Costs of Schizophrenia
Steven C. Marcus and Mark Olfson
Schizophrenia
Bulletin 2008 34(1):173-180
GRATIS 3! - Risk of
discontinuation of atypical antipsychotic agents in the treatment of
schizophrenia
C. Daniel Mullins,
Nour A. Obeidat, Brian J. Cuffel, John Naradzay
and Antony D. Loebel
Schizophrenia
Research.
Volume 98, Issues 1-3, January 2008, Pages 8-15
GRATIS 3 - Exploring
genetic variations that may be associated with the direct effects of some
antipsychotics on lipid levels
Jose de Leon, Juan Carlos Correa, Gualberto Ruaño, Andreas Windemuth, Maria J. Arranz and
Francisco J. Diaz
Schizophrenia Research. Volume 98, Issues 1-3, January 2008, Pages 40-46
GRATIS 4 -
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia:
The QUERISOLA trial
Emilio Sacchetti, Paolo Valsecchi, Giovanni Parrinello and for the
QUERISOLA Group
Schizophrenia
Research.
Volume 98, Issues 1-3, January 2008, Pages 55-65
GRATIS 3 - What is specific
to suicide in schizophrenia disorder
Demographic, clinical and behavioural dimensions
Alexander McGirr and Gustavo Turecki
Schizophrenia
Research.
Volume 98, Issues 1-3, January 2008, Pages 217-224
GRATIS 3! - Mortality in
schizophrenia and schizoaffective disorder: An
Rebecca M. Capasso, Timothy W. Lineberry, J.
Michael Bostwick, Paul A. Decker and Jennifer St. Sauver
Schizophrenia
Research.
Volume 98, Issues 1-3, January 2008, Pages 287-294
3 - Cardiac side effects of
psychiatric drugs
Paul Mackin
Human
Psychopharmacology: Clinical and Experimental. Volume 23,
Issue S1, Pages S3 - S14
3 - Haematological
toxicity of drugs used in psychiatry
Robert J. Flanagan, Louisa Dunk
Human
Psychopharmacology: Clinical and Experimental. Volume 23,
Issue S1, Pages S27 - S41
3 - Priapism associated with atypical antipsychotic
medications: a review
Sood, Shabnam; James,
William; Bailon, Maria-Jesus
International
Clinical Psychopharmacology. 23(1):9-17, January 2008
3 -
The Significance of Family History in First-Episode Schizophrenia Spectrum
Disorder.
Norman, Ross M. G; Manchanda,
Rahul; Malla, Ashok K; Harricharan, Raj; Northcott,
Sandra
Journal of Nervous & Mental Disease.
195(10):846-852, October 2007
3 -
Anhedonia and Social Adaptation Predict Substance
Abuse Evolution in Dual Diagnosis Schizophrenia
Stéphane Potvin;
Emmanuel Stip; Olivier Lipp;
Marc-André Roy; Marie-France Demers; Roch-Hugo
Bouchard; Alain Gendron
The American
Journal of Drug and Alcohol Abuse, Volume 34, Issue 1 January 2008, pages 75 -
82
5 -
Safety and Tolerability of Oral Paliperidone
Extended-Release Tablets in Elderly Patients With
Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month
Open-Label Extension
Andreas Tzimos, Viktor Samokhvalov,
Michelle Kramer, Lisa Ford, Cristiana Gassmann-Mayer,
Pilar Lim, and Mariëlle Eerdekens
Am J Geriatr Psychiatry 16:31-43, January 2008
| Regresar a RESÚMENES DICIEMBRE 2007" |